Australia markets closed

Cann Global Limited (CGB.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0050+0.0010 (+25.00%)
At close: 4:10PM AEDT
Full screen
Previous close0.0040
Bid0.0040 x 13220527400
Ask0.0050 x 1678304300
Day's range0.0040 - 0.0050
52-week range0.0030 - 0.0200
Avg. volume12,601,948
Market cap28.627M
Beta (5Y monthly)1.05
PE ratio (TTM)N/A
EPS (TTM)-0.0010
Earnings date31 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    Canntab Granted 3rd Patent and Receives $400K Purchase Order in Australia

    Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce the Australian Patent Office ("IP Australia") has granted Australian Patent No. AU 2018210690 to Canntab, related to its proprietary cannabidiol formulations with a priority date of January 23, 2017. The term of the patent expires on January 22, 2038.

  • Simply Wall St.

    Cann Global's (ASX:CGB) Stock Price Has Reduced 81% In The Past Three Years

    It is a pleasure to report that the Cann Global Limited ( ASX:CGB ) is up 83% in the last quarter. But that doesn't...